Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


28.08.2017

2 AJR Am J Roentgenol
1 Am J Epidemiol
1 Am J Respir Crit Care Med
1 Ann Oncol
12 Ann Thorac Surg
6 Anticancer Res
3 Arch Bronconeumol
2 BMC Cancer
1 Br J Cancer
1 Cancer
1 Cancer Cell
4 Cancer Lett
1 Chest
2 Clin Lung Cancer
2 Eur J Cancer
1 Eur Respir J
3 Int J Radiat Oncol Biol Phys
2 J Cancer Res Clin Oncol
6 J Clin Oncol
1 J Nucl Med
2 J Thorac Cardiovasc Surg
11 J Thorac Oncol
22 Lung Cancer
1 Mol Cancer Ther
1 Nat Med
1 Oncologist
1 PLoS Genet
10 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LEE C, Flynn MJ, Judy PF, Cody DD, et al
    Body Size-Specific Organ and Effective Doses of Chest CT Screening Examinations of the National Lung Screening Trial.
    AJR Am J Roentgenol. 2017 Mar 7:1-7. doi: 10.2214/AJR.16.16979.
    PubMed     Text format     Abstract available

  2. YIP R, Henschke CI, Xu DM, Li K, et al
    Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    AJR Am J Roentgenol. 2017;208:1011-1021.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  3. TUAL S, Lemarchand C, Boulanger M, Dalphin JC, et al
    Exposure to Farm Animals and Risk of Lung Cancer in the AGRICAN Cohort.
    Am J Epidemiol. 2017;186:463-472.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  4. DANDACHI N, Kelly NJ, Wood JP, Burton CL, et al
    Macrophage Elastase Induces TRAIL-mediated Tumor Cell Death through Its Carboxy-Terminal Domain.
    Am J Respir Crit Care Med. 2017;196:353-363.
    PubMed     Text format     Abstract available


    Ann Oncol

  5. CURIONI-FONTECEDRO A, Ickenberg C, Franzen D, Rogler G, et al
    Diffuse pseudoprogression in a patient with metastatic non-small-cell lung cancer treated with Nivolumab.
    Ann Oncol. 2017;28:2040-2041.
    PubMed     Text format    


    Ann Thorac Surg

  6. FUKUI M, Takamochi K, Oh S, Matsunaga T, et al
    Study on Perioperative Administration of a Neutrophil Elastase Inhibitor for Interstitial Pneumonias.
    Ann Thorac Surg. 2017;103:1781-1787.
    PubMed     Text format     Abstract available

  7. TOYOKAWA G, Takada K, Okamoto T, Kawanami S, et al
    Relevance Between Programmed Death Ligand 1 and Radiologic Invasiveness in Pathologic Stage I Lung Adenocarcinoma.
    Ann Thorac Surg. 2017 Mar 24. pii: S0003-4975(16)31841.
    PubMed     Text format     Abstract available

  8. BENDZSAK A, Waddell TK, Yasufuku K, Keshavjee S, et al
    Invasive Mediastinal Staging Guideline Concordance.
    Ann Thorac Surg. 2017;103:1736-1741.
    PubMed     Text format     Abstract available

  9. DONAHOE LL, de Valence M, Atenafu EG, Hanna WC, et al
    High Risk for Thoracotomy but not Thoracoscopic Lobectomy.
    Ann Thorac Surg. 2017;103:1730-1735.
    PubMed     Text format     Abstract available

  10. SAITO H, Konno H, Atari M, Kurihara N, et al
    Management of Intersegmental Plane on Pulmonary Segmentectomy Concerning Postoperative Complications.
    Ann Thorac Surg. 2017;103:1773-1780.
    PubMed     Text format     Abstract available

  11. SEDER CW, Raymond DP, Wright CD, Gaissert HA, et al
    The Society of Thoracic Surgeons General Thoracic Surgery Database 2017 Update on Outcomes and Quality.
    Ann Thorac Surg. 2017;103:1378-1383.
    PubMed     Text format     Abstract available

  12. ALVI N, Abraham RZ, Alexander P, Betlej T, et al
    Drains and Blushes: A Case of Impaired Venous Drainage Mimicking Pulmonary Torsion.
    Ann Thorac Surg. 2017;103:e521-e523.
    PubMed     Text format     Abstract available

  13. BOLUKBAS S, Biancosino C, Redwan B, Eberlein M, et al
    Diode-Pumped Laser for Lung-Sparing Surgical Treatment of Malignant Pleural Mesothelioma.
    Ann Thorac Surg. 2017;103:e529-e530.
    PubMed     Text format     Abstract available

  14. VELEZ-CUBIAN FO, Toosi K, Glover J, Pancholy B, et al
    Transient Aphonia After Mediastinoscopy.
    Ann Thorac Surg. 2017;103:e549-e550.
    PubMed     Text format     Abstract available

  15. INOUE M
    Careful Indications for Intentional Segmentectomy in cT1aN0 Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2017;104:1095-1096.
    PubMed     Text format    

  16. KAWADA T
    Socioeconomic Factors and Readmission in Patients With Early-Stage Lung Cancer After Lobectomy.
    Ann Thorac Surg. 2017;104:1098.
    PubMed     Text format    

  17. CHAFT JE, Hellmann MD, Velez MJ, Travis WD, et al
    Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors.
    Ann Thorac Surg. 2017;104:e217-e218.
    PubMed     Text format     Abstract available


    Anticancer Res

  18. RIZZARDI C, Athanasakis E, Cammisuli F, Monego SD, et al
    Puzzling Results from BAP1 Germline Mutations Analysis in a Group of Asbestos-Exposed Patients in a High-risk Area of Northeast Italy.
    Anticancer Res. 2017;37:3073-3083.
    PubMed     Text format     Abstract available

  19. MENCOBONI M, Filiberti RA, Taveggia P, Del Corso L, et al
    Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC.
    Anticancer Res. 2017;37:3189-3194.
    PubMed     Text format     Abstract available

  20. KADERBHAI C, Richard C, Fumet JD, Aarnink A, et al
    Antibiotic Use Does Not Appear to Influence Response to Nivolumab.
    Anticancer Res. 2017;37:3195-3200.
    PubMed     Text format     Abstract available

  21. SINAGRA E, Raimondo D, Gallo E, Stella M, et al
    JC Virus and Lung Adenocarcinoma: Fact or Myth?
    Anticancer Res. 2017;37:3311-3314.
    PubMed     Text format     Abstract available

  22. ARIYASU R, Horiike A, Yoshizawa T, Dotsu Y, et al
    Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy.
    Anticancer Res. 2017;37:4229-4232.
    PubMed     Text format     Abstract available

  23. KOBAYASHI H, Hamasaki M, Morishita T, Inoue T, et al
    Analysis of Evolving Clinicopathological Features of Metastatic Brain Tumors Over 30 Years of Surgical Management.
    Anticancer Res. 2017;37:3969-3974.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  24. HERNANDEZ HERNANDEZ JR
    The Pulmonologist-Patient Relationship After the Lung Cancer Committee Decision.
    Arch Bronconeumol. 2017 Aug 21. pii: S0300-2896(17)30260.
    PubMed     Text format    

  25. SANCHEZ DE COS ESCUIN J
    New Immunotherapy and Lung Cancer.
    Arch Bronconeumol. 2017 Aug 17. pii: S0300-2896(17)30225.
    PubMed     Text format     Abstract available

  26. MATILLA GONZALEZ JM
    Lung Cancer Surgery in the xxi Century.
    Arch Bronconeumol. 2017 Aug 11. pii: S0300-2896(17)30255.
    PubMed     Text format    


    BMC Cancer

  27. LEE YS, Nam HS, Lim JH, Kim JS, et al
    Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
    BMC Cancer. 2017;17:557.
    PubMed     Text format     Abstract available

  28. SZTANKAY M, Giesinger JM, Zabernigg A, Krempler E, et al
    Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
    BMC Cancer. 2017;17:565.
    PubMed     Text format     Abstract available


    Br J Cancer

  29. BAHLEDA R, Grilley-Olson JE, Govindan R, Barlesi F, et al
    Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies.
    Br J Cancer. 2017;116:1505-1512.
    PubMed     Text format     Abstract available


    Cancer

  30. PRINTZ C
    Nivolumab improves survival for patients with advanced lung cancer.
    Cancer. 2017;123:3211.
    PubMed     Text format    


    Cancer Cell

  31. BEST MG, Sol N, In 't Veld SGJG, Vancura A, et al
    Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
    Cancer Cell. 2017;32:238-252.
    PubMed     Text format     Abstract available


    Cancer Lett

  32. WU J, He Z, Yang XM, Li KL, et al
    RCCD1 depletion attenuates TGF-beta-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells.
    Cancer Lett. 2017;400:18-29.
    PubMed     Text format     Abstract available

  33. ZHOU L, Lv T, Zhang Q, Zhu Q, et al
    The biology, function and clinical implications of exosomes in lung cancer.
    Cancer Lett. 2017 Aug 12. pii: S0304-3835(17)30480.
    PubMed     Text format     Abstract available

  34. YANG D, Cao X, Wang F, Jiang H, et al
    LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
    Cancer Lett. 2017;400:137-148.
    PubMed     Text format     Abstract available

  35. GORZALCZANY Y, Akiva E, Klein O, Merimsky O, et al
    Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor.
    Cancer Lett. 2017;397:23-32.
    PubMed     Text format     Abstract available


    Chest

  36. CHERIAN SV, Estrada-Y-Martin RM, Irani AD, Zhou J, et al
    A 33-Year-Old Woman With a Fluorodeoxyglucose-Avid Left Lower Lobe Mass.
    Chest. 2017;151:e119-e122.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  37. ALEXANDER M, Solomon B, Burbury K
    Thromboembolism in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Jul 22. pii: S1525-7304(17)30209.
    PubMed     Text format    

  38. WEST HL, Moon J, Wozniak AJ, Mack P, et al
    Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30203.
    PubMed     Text format     Abstract available


    Eur J Cancer

  39. JIANG T, Ren S, Li X, Su C, et al
    The changing diagnostic pathway for lung cancer patients in Shanghai, China.
    Eur J Cancer. 2017;84:168-172.
    PubMed     Text format     Abstract available

  40. LI F, Zhu T, Cao B, Wang J, et al
    Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance.
    Eur J Cancer. 2017;84:184-192.
    PubMed     Text format     Abstract available


    Eur Respir J

  41. GLATZER M, Rittmeyer A, Muller J, Opitz I, et al
    Treatment of limited disease small cell lung cancer: the multidisciplinary team.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  42. KIM TH, Kim MH, Kim BJ, Park SI, et al
    Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:1124-1131.
    PubMed     Text format     Abstract available

  43. SHAVERDIAN N, Yoo SM, Cook R, Chang EM, et al
    Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine Residents.
    Int J Radiat Oncol Biol Phys. 2017;98:1153-1161.
    PubMed     Text format     Abstract available

  44. FAUGHT AM, Yamamoto T, Castillo R, Castillo E, et al
    Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:202-209.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  45. LIAO YH, Li CI, Lin CC, Lin JG, et al
    Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients.
    J Cancer Res Clin Oncol. 2017 Aug 12. doi: 10.1007/s00432-017-2491.
    PubMed     Text format     Abstract available

  46. GU C, Wang R, Pan X, Huang Q, et al
    Sublobar resection versus lobectomy in patients aged </=35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    J Cancer Res Clin Oncol. 2017 Aug 17. doi: 10.1007/s00432-017-2499.
    PubMed     Text format     Abstract available


    J Clin Oncol

  47. GAUTSCHI O, Milia J, Filleron T, Wolf J, et al
    Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.
    J Clin Oncol. 2017;35:1403-1410.
    PubMed     Text format     Abstract available

  48. RAMALINGAM SS, Yang JC, Lee CK, Kurata T, et al
    Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2017 Aug 25:JCO2017747576. doi: 10.1200/JCO.2017.74.7576.
    PubMed     Text format     Abstract available

  49. BRASKY TM, White E, Chen CL
    Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort.
    J Clin Oncol. 2017 Aug 22:JCO2017727735. doi: 10.1200/JCO.2017.72.7735.
    PubMed     Text format     Abstract available

  50. OTT PA, Elez E, Hiret S, Kim DW, et al
    Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study.
    J Clin Oncol. 2017 Aug 16:JCO2017725069. doi: 10.1200/JCO.2017.72.5069.
    PubMed     Text format     Abstract available

  51. HANNA N, Johnson D, Temin S, Baker S Jr, et al
    Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    J Clin Oncol. 2017 Aug 14:JCO2017746065. doi: 10.1200/JCO.2017.74.6065.
    PubMed     Text format     Abstract available

  52. TAYLOR C, Correa C, Duane FK, Aznar MC, et al
    Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.
    J Clin Oncol. 2017 Mar 20:JCO2016720722. doi: 10.1200/JCO.2016.72.0722.
    PubMed     Text format     Abstract available


    J Nucl Med

  53. WARNDERS FJ, Terwisscha van Scheltinga AG, Knuehl C, van Roy M, et al
    HER3 specific biodistribution and tumor uptake of 89Zr-MSB0010853 visualized by real-time and non-invasive PET imaging.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.181586. doi: 10.2967/jnumed.116.181586.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  54. DIGESU CS, Colson YL
    A "green" light for staging in early lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134-1136.
    PubMed     Text format    

  55. LIU C, Liu L
    Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134.
    PubMed     Text format    


    J Thorac Oncol

  56. SEPESI B, Correa AM, Dmitrovsky E, Liu X, et al
    Reply to "Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer: Methodological Issues".
    J Thorac Oncol. 2017;12:e150-e151.
    PubMed     Text format    

  57. SAFIRI S, Khazaei S, Ayubi E
    The Influence of Body Mass Index on Overall Survival following Surgical Resection of Non-Small Cell Lung Cancer: Methodological Issues.
    J Thorac Oncol. 2017;12:e149-e150.
    PubMed     Text format    

  58. KHUNGER M, Calabrese C, Kontzias A, Velcheti V, et al
    To Treat or Not to Treat: Role of Immunotherapy in Patients with Concomitant Diagnosis of Advanced-Stage Non-Small Cell Lung Cancer and Psoriasis.
    J Thorac Oncol. 2017;12:e147-e149.
    PubMed     Text format    

  59. KOMATSU T, Nakamura K, Kawase A
    Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer.
    J Thorac Oncol. 2017;12:e143-e144.
    PubMed     Text format    

  60. FUNAZO T, Nomizo T, Kim YH
    Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Treated with Nivolumab.
    J Thorac Oncol. 2017;12:e140-e141.
    PubMed     Text format    

  61. GORTAIS H, Daniel C, Bidard FC, Jeannot E, et al
    T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis.
    J Thorac Oncol. 2017;12:e138-e139.
    PubMed     Text format    

  62. EZE C, Roengvoraphoj O, Manapov F
    Prophylactic Cranial Irradiation in Resected Small Cell Lung Cancer: Comprehensive Staging, Adjuvant Chemotherapy, and Strict Stratification of Pathological Stage Play a Role.
    J Thorac Oncol. 2017;12:e137-e138.
    PubMed     Text format    

  63. VAN SCHIL PE
    Optimal Treatment of Stage IIIA-N2 Non-Small Cell Lung Cancer: A Neverending Story?
    J Thorac Oncol. 2017;12:1338-1340.
    PubMed     Text format    

  64. GU F, Cheung LC, Freedman ND, Katki HA, et al
    Potential impact of including Time to First Cigarette into risk models for selecting ever-smokers for lung-cancer screening.
    J Thorac Oncol. 2017 Aug 14. pii: S1556-0864(17)30664.
    PubMed     Text format     Abstract available

  65. LIN JJ, Shaw AT
    Recent Advances in Targeting ROS1 in Lung Cancer.
    J Thorac Oncol. 2017 Aug 14. pii: S1556-0864(17)30668.
    PubMed     Text format     Abstract available

  66. KONO M, Allen PK, Lin SH, Wei X, et al
    Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival.
    J Thorac Oncol. 2017 Aug 10. pii: S1556-0864(17)30661.
    PubMed     Text format     Abstract available


    Lung Cancer

  67. SCHONEWOLF CA, Verma V, Post CM, Berman AT, et al
    Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
    Lung Cancer. 2017 Jul 14. pii: S0169-5002(17)30384.
    PubMed     Text format     Abstract available

  68. CHENG YW, Chiou HL, Chen JT, Chou MC, et al
    Corrigendum to: 'Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan' [Lung Cancer 46 (November(2)) (2004) 165-170].
    Lung Cancer. 2017 Aug 18. pii: S0169-5002(17)30486.
    PubMed     Text format    

  69. MORIKAWA N, Inoue A, Sugawara S, Maemondo M, et al
    Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naive extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901.
    Lung Cancer. 2017;111:38-42.
    PubMed     Text format     Abstract available

  70. SHEN L, Niu X, Jian H, Xu Y, et al
    Assessment of interfering factors and clinical risk associated with discontinuation of pemetrexed maintenance therapy in advanced non-squamous non-small cell lung cancer.
    Lung Cancer. 2017;111:43-50.
    PubMed     Text format     Abstract available

  71. CALIFANO R, Greystoke A, Lal R, Thompson J, et al
    Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer.
    Lung Cancer. 2017;111:51-58.
    PubMed     Text format     Abstract available

  72. CAPELAN M, Roda D, Geuna E, Rihawi K, et al
    Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?
    Lung Cancer. 2017;111:6-11.
    PubMed     Text format     Abstract available

  73. TOKACA N, Wotherspoon A, Nicholson AG, Fotiadis N, et al
    Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer.
    Lung Cancer. 2017;111:65-68.
    PubMed     Text format     Abstract available

  74. MOON SM, Lee DG, Hwang NY, Ahn S, et al
    Ipsilateral pleural recurrence after diagnostic transthoracic needle biopsy in pathological stage I lung cancer patients who underwent curative resection.
    Lung Cancer. 2017;111:69-74.
    PubMed     Text format     Abstract available

  75. LIM SM, Chang H, Cha YJ, Liang S, et al
    Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer.
    Lung Cancer. 2017;111:79-83.
    PubMed     Text format     Abstract available

  76. MIURA K, Hamanaka K, Koizumi T, Kitaguchi Y, et al
    Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: Comparative study of normal lung, emphysema, and pulmonary fibrosis.
    Lung Cancer. 2017;111:88-95.
    PubMed     Text format     Abstract available

  77. ROUSSEAU-GAZANIOL C, Fraboulet S, Couderc LJ, Kreis H, et al
    Lung cancer in renal transplant recipients: A case-control study.
    Lung Cancer. 2017;111:96-100.
    PubMed     Text format     Abstract available

  78. GOBBINI E, Galetta D, Tiseo M, Graziano P, et al
    Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.
    Lung Cancer. 2017;111:30-37.
    PubMed     Text format     Abstract available

  79. LABBE C, Cabanero M, Korpanty GJ, Tomasini P, et al
    Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
    Lung Cancer. 2017;111:23-29.
    PubMed     Text format     Abstract available

  80. FUJIMOTO D, Morimoto T, Ito J, Sato Y, et al
    A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia.
    Lung Cancer. 2017;111:1-5.
    PubMed     Text format     Abstract available

  81. TAGHIZADEH N, Taylor KL, MacEachern P, Koetzler R, et al
    Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
    Lung Cancer. 2017;111:101-107.
    PubMed     Text format     Abstract available

  82. GAGLIASSO M, Migliaretti G, Ardissone F
    Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery.
    Lung Cancer. 2017;111:124-130.
    PubMed     Text format     Abstract available

  83. YOUSAF-KHAN AU, van der Aalst CM, Aerts JGJV, den Bakker MA, et al
    Uniform and blinded cause of death verification of the NELSON lung cancer screening participants.
    Lung Cancer. 2017;111:131-134.
    PubMed     Text format     Abstract available

  84. WOHLKOENIG C, Leithner K, Olschewski A, Olschewski H, et al
    TR3 is involved in hypoxia-induced apoptosis resistance in lung cancer cells downstream of HIF-1alpha.
    Lung Cancer. 2017;111:15-22.
    PubMed     Text format     Abstract available

  85. RUELLE L, Bentea G, Sideris S, El Koulali M, et al
    Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles.
    Lung Cancer. 2017;111:150-163.
    PubMed     Text format     Abstract available

  86. SCULIER C, Bentea G, Ruelle L, Grigoriu B, et al
    Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions.
    Lung Cancer. 2017;111:164-175.
    PubMed     Text format     Abstract available

  87. DIEM S, Schmid S, Krapf M, Flatz L, et al
    Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Lung Cancer. 2017;111:176-181.
    PubMed     Text format     Abstract available

  88. HATA A, Katakami N, Nanjo S, Okuda C, et al
    Programmed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancer.
    Lung Cancer. 2017;111:182-189.
    PubMed     Text format     Abstract available


    Mol Cancer Ther

  89. WATANABE S, Yoshida T, Kawakami H, Takegawa N, et al
    T790M-selective EGFR-TKI combined with dasatinib as an optimal strategy for overcoming EGFR-TKI resistance in T790M-positive non-small cell lung cancer.
    Mol Cancer Ther. 2017 Aug 24. pii: molcanther.0351.2017.
    PubMed     Text format     Abstract available


    Nat Med

  90. RICKMAN DS, Beltran H, Demichelis F, Rubin MA, et al
    Biology and evolution of poorly differentiated neuroendocrine tumors.
    Nat Med. 2017;23:1-10.
    PubMed     Text format     Abstract available


    Oncologist

  91. PAI-SCHERF L, Blumenthal GM, Li H, Subramaniam S, et al
    FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.
    Oncologist. 2017 Aug 23. pii: theoncologist.2017-0078.
    PubMed     Text format     Abstract available


    PLoS Genet

  92. PU M, Li C, Qi X, Chen J, et al
    MiR-1254 suppresses HO-1 expression through seed region-dependent silencing and non-seed interaction with TFAP2A transcript to attenuate NSCLC growth.
    PLoS Genet. 2017;13:e1006896.
    PubMed     Text format     Abstract available


    PLoS One

  93. ECHTLER K, Konrad I, Lorenz M, Schneider S, et al
    Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.
    PLoS One. 2017;12:e0172788.
    PubMed     Text format     Abstract available

  94. ASOR E, Stav MY, Simon E, Fahoum I, et al
    Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy.
    PLoS One. 2017;12:e0173760.
    PubMed     Text format     Abstract available

  95. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Text format     Abstract available

  96. ZHANG C, Wei B, Li P, Yang K, et al
    Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs.
    PLoS One. 2017;12:e0173524.
    PubMed     Text format     Abstract available

  97. KONG GM, Yu M, Gu Z, Chen Z, et al
    Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity.
    PLoS One. 2017;12:e0181601.
    PubMed     Text format     Abstract available

  98. YANG JH, Li XY, Wang X, Hou WJ, et al
    Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.
    PLoS One. 2017;12:e0182775.
    PubMed     Text format     Abstract available

  99. CHEN L, Lu J, Huang T, Cai YD, et al
    A computational method for the identification of candidate drugs for non-small cell lung cancer.
    PLoS One. 2017;12:e0183411.
    PubMed     Text format     Abstract available

  100. JOVELET C, Madic J, Remon J, Honore A, et al
    Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer.
    PLoS One. 2017;12:e0183319.
    PubMed     Text format     Abstract available

  101. SHIN J, Song SY, Ahn HS, An BC, et al
    Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.
    PLoS One. 2017;12:e0183896.
    PubMed     Text format     Abstract available

  102. CHOUAID C, Debieuvre D, Durand-Zaleski I, Fernandes J, et al
    Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).
    PLoS One. 2017;12:e0182798.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: